The stock is struggling badly, and if things don't improve in short order, Eli Lilly will be on track for its worst ...

Key Takeaways A new daily pill helped people lose an average of 27 poundsThe pill may be easier to make and use than injectable weight loss drugsSide effects were mostly stomach-related, like vomiting ...

Watch AppLovin (APP) shares today. APP stock gained nearly 12% to close at $437.34, after posting strong quarterly results.

Lilly executives have touted the once-daily pill, known as orforglipron, as a cheaper alternative to recently-popular obesity ...

Wall Street rose on Friday, setting up a strong finish to the week, after President Donald Trump's interim pick for a Fed ...

During a 72-week study, those taking the highest dose of orforglipron lost an average of 27.3 pounds. While injections might cause people to lose more weight, a pill has advantages over them, ...